Search

everythinglearnresearchcommunity

for

Search:↓

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Balding might help identify men at higher risk for severe COVID-19, but more research is needed.

Long COVID causes various long-term health issues and needs better awareness and treatment.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Long COVID patients may have hormonal imbalances linked to their symptoms.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

Possible link between androgens and COVID-19 severity; more research needed.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

COVID-19 can cause various skin issues, but long-term skin problems are rare.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

COVID-19 may lead to severe skin necrosis without clear underlying causes, as seen in a diabetic patient who required leg amputation.

COVID-19 can cause different skin issues, including rashes and hair loss.

No single biomarker is reliable enough for diagnosing and assessing SLE.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

No significant link between male pattern baldness and COVID-19 severity was found.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.